Physician profile
Rona Marie Dellinger
NPI 1275537045
$6,505.40
in general payments reported to CMS, 2019-2025
32 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $981 · 2022: $1,253 · 2023: $1,620 · 2024: $1,358 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,271.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,379.86 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $946.84 | 2021-2025 | |
| Novo Nordisk INC | $831.61 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $613.22 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $477.40 | 2021-2025 | Repatha, Otezla, Evenity |
| Abbott Laboratories | $320.62 | 2021-2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $278.98 | 2021-2025 | Jardiance |
| Nestle Healthcare Nutrition INC. | $209.97 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $196.78 | 2021-2023 | |
| Exact Sciences Corporation | $183.93 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $96.56 | 2022-2023 | |
| Insulet Corporation | $96.23 | 2022-2025 | Omnipod |
| Novartis Pharmaceuticals Corporation | $88.89 | 2021-2025 | |
| Axsome Therapeutics, INC. | $87.68 | 2023-2024 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $73.60 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $73.55 | 2021-2023 | Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.59 | 2023-2025 | Xifaxan |
| Pfizer INC. | $66.83 | 2022-2025 | |
| Ironshore Pharmaceuticals INC. | $52.69 | 2022-2024 | |
| United Therapeutics Corporation | $48.72 | 2024 | |
| Dexcom, INC. | $43.41 | 2021-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $37.91 | 2023-2025 | Kyphon Express II Kyphopak Tray |
| Amarin Pharma, INC. | $34.40 | 2021-2022 | |
| Corium, LLC | $31.66 | 2024 | Azstarys |
| Biohaven Pharmaceutical Holding Company LTD. | $31.21 | 2022 | |
| Astellas Pharma US INC | $28.93 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.97 | 2021 | |
| Collegium Pharmaceutical, INC. | $18.03 | 2025 | Jornay Pm |
| Actelion Pharmaceuticals US, INC. | $17.79 | 2024 | Opsumit, Uptravi |
| Aimmune Therapeutics, INC. | $17.12 | 2024 | |
| Esperion Therapeutics, INC. | $15.75 | 2024 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $13.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rona Dellinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.